Selected research
Industry Research
Ceftazidime Industry Research Report 2026
Market perspective
The global Ceftazidime market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ceftazidime is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ceftazidime is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ceftazidime is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ceftazidime include Fujian Fukang Pharmaceutical, NCPC, United Laboratories, Sinopharm Sandwich, Shanghai Pharmaceutical, Union Chempharma and Youcare Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ceftazidime market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ceftazidime Market by Company
Fujian Fukang Pharmaceutical
NCPC
United Laboratories
Sinopharm Sandwich
Shanghai Pharmaceutical
Union Chempharma
Youcare Pharmaceutical
Ceftazidime Segment by Type
Powder Injection
Injection
Ceftazidime Segment by Application
Respiratory Infections
Urinary Infections
Skin Infections
Other
Ceftazidime Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftazidime market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ceftazidime and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftazidime.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ceftazidime manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ceftazidime by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ceftazidime in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder Injection
- Injection
Applications
- Respiratory Infections
- Urinary Infections
- Skin Infections
- Other
Companies covered
- Fujian Fukang Pharmaceutical
- NCPC
- United Laboratories
- Sinopharm Sandwich
- Shanghai Pharmaceutical
- Union Chempharma
- Youcare Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ceftazidime Market Size (2021-2032)
- 2.2.2 Global Ceftazidime Sales (2021-2032)
- 2.2.3 Global Ceftazidime Market Average Price (2021-2032)
- 2.3 Ceftazidime by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder Injection
- 2.3.3 Injection
- 2.4 Ceftazidime by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Respiratory Infections
- 2.4.3 Urinary Infections
- 2.4.4 Skin Infections
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ceftazidime Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ceftazidime Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Ceftazidime Revenue of Manufacturers (2021-2026)
- 3.4 Global Ceftazidime Average Price by Manufacturers (2021-2026)
- 3.5 Global Ceftazidime Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ceftazidime, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ceftazidime, Product Type & Application
- 3.8 Global Manufacturers of Ceftazidime, Established Date
- 3.9 Global Ceftazidime Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fujian Fukang Pharmaceutical
- 4.1.1 Fujian Fukang Pharmaceutical Company Information
- 4.1.2 Fujian Fukang Pharmaceutical Business Overview
- 4.1.3 Fujian Fukang Pharmaceutical Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fujian Fukang Pharmaceutical Ceftazidime Product Portfolio
- 4.1.5 Fujian Fukang Pharmaceutical Recent Developments
- 4.2 NCPC
- 4.2.1 NCPC Company Information
- 4.2.2 NCPC Business Overview
- 4.2.3 NCPC Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 NCPC Ceftazidime Product Portfolio
- 4.2.5 NCPC Recent Developments
- 4.3 United Laboratories
- 4.3.1 United Laboratories Company Information
- 4.3.2 United Laboratories Business Overview
- 4.3.3 United Laboratories Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 United Laboratories Ceftazidime Product Portfolio
- 4.3.5 United Laboratories Recent Developments
- 4.4 Sinopharm Sandwich
- 4.4.1 Sinopharm Sandwich Company Information
- 4.4.2 Sinopharm Sandwich Business Overview
- 4.4.3 Sinopharm Sandwich Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sinopharm Sandwich Ceftazidime Product Portfolio
- 4.4.5 Sinopharm Sandwich Recent Developments
- 4.5 Shanghai Pharmaceutical
- 4.5.1 Shanghai Pharmaceutical Company Information
- 4.5.2 Shanghai Pharmaceutical Business Overview
- 4.5.3 Shanghai Pharmaceutical Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Pharmaceutical Ceftazidime Product Portfolio
- 4.5.5 Shanghai Pharmaceutical Recent Developments
- 4.6 Union Chempharma
- 4.6.1 Union Chempharma Company Information
- 4.6.2 Union Chempharma Business Overview
- 4.6.3 Union Chempharma Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Union Chempharma Ceftazidime Product Portfolio
- 4.6.5 Union Chempharma Recent Developments
- 4.7 Youcare Pharmaceutical
- 4.7.1 Youcare Pharmaceutical Company Information
- 4.7.2 Youcare Pharmaceutical Business Overview
- 4.7.3 Youcare Pharmaceutical Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Youcare Pharmaceutical Ceftazidime Product Portfolio
- 4.7.5 Youcare Pharmaceutical Recent Developments
5 Global Ceftazidime Market Scenario by Region
- 5.1 Global Ceftazidime Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ceftazidime Sales by Region: 2021-2032
- 5.2.1 Global Ceftazidime Sales by Region: 2021-2026
- 5.2.2 Global Ceftazidime Sales by Region: 2027-2032
- 5.3 Global Ceftazidime Revenue by Region: 2021-2032
- 5.3.1 Global Ceftazidime Revenue by Region: 2021-2026
- 5.3.2 Global Ceftazidime Revenue by Region: 2027-2032
- 5.4 North America Ceftazidime Market Facts & Figures by Country
- 5.4.1 North America Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ceftazidime Sales by Country (2021-2032)
- 5.4.3 North America Ceftazidime Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ceftazidime Market Facts & Figures by Country
- 5.5.1 Europe Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ceftazidime Sales by Country (2021-2032)
- 5.5.3 Europe Ceftazidime Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ceftazidime Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ceftazidime Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ceftazidime Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ceftazidime Market Facts & Figures by Country
- 5.7.1 South America Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ceftazidime Sales by Country (2021-2032)
- 5.7.3 South America Ceftazidime Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ceftazidime Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ceftazidime Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ceftazidime Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ceftazidime Sales by Type (2021-2032)
- 6.1.1 Global Ceftazidime Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Ceftazidime Sales Market Share by Type (2021-2032)
- 6.2 Global Ceftazidime Revenue by Type (2021-2032)
- 6.2.1 Global Ceftazidime Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ceftazidime Revenue Market Share by Type (2021-2032)
- 6.3 Global Ceftazidime Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ceftazidime Sales by Application (2021-2032)
- 7.1.1 Global Ceftazidime Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Ceftazidime Sales Market Share by Application (2021-2032)
- 7.2 Global Ceftazidime Revenue by Application (2021-2032)
- 7.2.1 Global Ceftazidime Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ceftazidime Revenue Market Share by Application (2021-2032)
- 7.3 Global Ceftazidime Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ceftazidime Value Chain Analysis
- 8.1.1 Ceftazidime Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ceftazidime Production Mode & Process
- 8.2 Ceftazidime Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ceftazidime Distributors
- 8.2.3 Ceftazidime Customers
9 Global Ceftazidime Analyzing Market Dynamics
- 9.1 Ceftazidime Industry Trends
- 9.2 Ceftazidime Industry Drivers
- 9.3 Ceftazidime Industry Opportunities and Challenges
- 9.4 Ceftazidime Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst